JAMA · 1965 · 104 citations · 16 references
MedicineEndocrinologyInternal MedicineEndocrine PharmacotherapyEndocrine SurgeryNeuroendocrinologyAdrenal DisordersAdrenal EndocrinologyAdrenal HormonesAdrenal Steroid HormonesEndocrine AssessmentEndocrine TestingAdrenal PathophysiologyAdrenocorticotropic Hormone TestingCushing Syndrome ScreeningRapid Screening TestsScreening Test SelectionScreening Test Validity
The suppressibility of morning plasma 17-hydroxycorticosteroid (17-OHCS) levels by 1 mg dexamethasone given by mouth at 11 pm the preceding night was used as a screening test for Cushing's syndrome. Plasma 17-OHCS in 16 normal subjects, 20 with simple obesity and 10 with diseases other than Cushing's syndrome were suppressed to levels below 5μg/100 ml. In contrast, in 17 patients with Cushing's syndrome, the lowest observed value was 13μg/100 ml and no false-negative results were obtained. Two obese, hirsute women proved to be partial responders only, as their plasma levels were not suppressed below 10.5μg/100 ml. Mild abnormalities of adrenal cortical secretory activity may be present in such cases. Therefore, a single morning 17-OHCS value of less than 5μg/100 ml plasma should exclude Cushing's syndrome.
16
RICHARD P. DOE, Jack A. Vennes, Edmund B. Flink et al. · The Journal of Clinical Endocrinology & Metabolism · 1960 · 138 citations
Nicholas P. Christy, Eleanor Z. Wallace, Joseph W. Jailer · Journal of Clinical Investigation · 1955 · 105 citations · Full text